Non-executive directors are appointed by the Trust's Council of Governors on a four year fixed-term contract. They are either residents of the local community, or King's patients. They bring a wide range of skill and experience to the organisation.
Collectively, they provide strategic guidance, support and challenge to the Trust to ensure it meets its objectives.
Biography to follow
Nicholas Campbell-Watts has spent much of his career working with people and communities experiencing multiple and complex health and social care challenges linked to mental health, learning disabilities, homelessness, or offending. He has predominantly worked at a senior level in the voluntary sector. He currently works for Certitude, a charity that supports people across London who have learning disabilities, autism, and mental health needs.
Nicholas has a track record of involvement in system and organisational change and transformation, and has previous experience as a Non-Executive Director at Lambeth NHS Primary Care Trust. He has lived and worked in south London for over 30 years and currently lives in Lewisham. He is married with three children.
Professor Ghulam J Mufti
Professor Mufti has worked at the Trust since 1985 when he was appointed as a senior lecturer/consultant haematologist. His current appointment is Professor of Haemato-oncology,Clinical Director of Pathology and Head of the Department of Haematology, one of the largest in Europe. Ghulam is internationally renowned for research and treatment of myelodysplastic syndromes (MDS) and other pre-leukaemic diseases, and has published over 400 original papers in medical journals.
He is founding member of the International MDS foundation Board, Chair of the UK MDS Forum and Member of GSTS Members Board. He was formerly a member of the scientific committee of Leukaemia & Lymphoma Research. In 2017 he was awarded an OBE for services to haematological medicine. He has been a non-executive director of the Trust since December 2012.
Professor Jonathan Cohen
Professor Cohen completed his medical degree at Charing Cross Hospital Medical School in 1975 and has worked in the NHS in the field of infectious diseases for over 30 years, becoming Chair and Head of Department at Hammersmith Hospital and Imperial College School of Medicine. His research interest is severe bacterial infections and he has an international reputation for his work in helping to develop new forms of treatment for sepsis and septic shock.
He was the founding Dean of Brighton and Sussex Medical School, which has already provided over 700 new doctors to the NHS. He has also served as member or Chair for a wide range of national and international bodies, and spent five years as Editor-in-Chief of the International Journal of Infectious Diseases. He is currently President of the International Society for Infectious Diseases, a trustee of Arthritis Research UK and member of the Scientific Advisory Board of the Lister Institute.
Professor Richard Trembath
Professor Trembath completed his medical degree at Guy’s Hospital Medical School in 1981. He is a Clinician Scientist internationally recognised for sustained contributions to medical science through the development and application of genetics and genomics to an enhanced understanding of the pathogenesis of rare and common human disease. He has championed translational bio-medical research and provides leadership for academia in the UK and beyond. His research interests include the identification and characterisation of genes and the molecular pathways underlying a range of human common and rare disorders.
Currently he is the Executive Dean at the Faculty of Life Sciences and Medicine, King’s College London, and Professor of Medical Genetics. From 2011 to 2015 he was Vice-Principal for Health at Queen Mary University of London and a non-executive director at Barts Health NHS Trust. He was a founding Director of the National Institute for Health Research Comprehensive Biomedical Research Centre in association with Guy's and St Thomas' NHS Foundation Trust. He is a Fellow of the Academy of Medical Sciences and a former Senior Investigator for the National Institute of Health Research. He joined the King's Board in December 2016.
Sir Hugh Taylor - Interim Chair
Sir Hugh was appointed Interim Chair in February 2019. He had a long and distinguished career in the civil service which included senior roles in the NHS Executive, the Cabinet Office, the Home Office, and the Department of Health, where he was made Permanent Secretary. He retired from this role in July 2010.
Sir Hugh is Chairman of the Board of Governors of the Health Foundation, and a Trustee of Cicely Saunders International. He is a former Chair of the National Skills Academy for Health, and between 2011 and 2017 he was a Trustee of Macmillan Cancer Support and the Nuffield Trust.
Sir Hugh is also Chair of Guy’s and St Thomas’ NHS Foundation Trust, and a Southwark resident. He is committed to improving health services in South East London.
Steve Weiner has spent most of his career in finance with international consumer goods group Unilever. He retired from his role as Global Controller and part of Unilever’s finance leadership team in 2018.
He has extensive experience in making operational and commercial decisions involving large budgets and complex financial constraints, and in leading and developing multicultural teams.
Sue Slipman - Deputy Chair
Sue Slipman was the founding Chief Executive of the Foundation Trust Network, the national trades associations for authorised and aspirant foundation trusts in the NHS. She was also Director of the campaigning charity The National Council for One Parent Families, and ran the Gas Consumers Council.
She was an Executive Director at Camelot where she held the role of Director of Corporate Responsibility before becoming Director of Communications. She has been Chair of the Financial Ombudsman Service, has held a number of non-executive positions in public life and is currently a trustee of NEST Corporation, the pension scheme set up by government to support auto-enrolment.